MSON has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MSON has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pretax income is the income that a company earns before paying income taxes. Misonix's pretax income for the three months ended in Jun. 2021 was $-4.34 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2021 was $-14.34 Mil. Misonix's pretax margin was -22.05%.
During the past 13 years, Misonix's highest Pretax Margin was 11.34%. The lowest was -35.08%. And the median was -9.37%.
The historical data trend for Misonix's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Misonix Annual Data | |||||||||||||||||||||
Trend | Jun12 | Jun13 | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | |||||||||||
Pre-Tax Income | Get a 7-Day Free Trial | -2.87 | -2.39 | -7.36 | -21.92 | -14.34 |
Misonix Quarterly Data | ||||||||||||||||||||
Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | |
Pre-Tax Income | Get a 7-Day Free Trial | -8.50 | -4.98 | -1.27 | -3.76 | -4.34 |
For the Medical Devices subindustry, Misonix's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Misonix's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Misonix's Pre-Tax Income falls into.
This is the income that a company earns before paying income taxes.
Misonix's Pretax Income for the fiscal year that ended in Jun. 2021 is calculated as
Pretax Income | = | Operating Income | + | Non Operating Income | + | Interest Expense | + | Interest Income | + | Other |
= | -11.036 | + | 0.304 | + | -3.62 | + | 0.01 | + | 0.00099999999999945 | |
= | -14.34 |
Misonix's Pretax Income for the quarter that ended in Jun. 2021 is calculated as
Pretax Income | = | Operating Income | + | Non Operating Income | + | Interest Expense | + | Interest Income | + | Other |
= | -3.774 | + | 0.302 | + | -0.87 | + | 0.002 | + | -0.00099999999999945 | |
= | -4.34 |
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Misonix (NAS:MSON) Pre-Tax Income Explanation
Misonix's Pretax Margin for the quarter that ended in Jun. 2021 is calculated as
Pretax Margin | = | Pretax Income | / | Revenue |
= | -4.341 | / | 19.685 | |
= | -22.05% |
During the past 13 years, Misonix's highest Pretax Margin was 11.34%. The lowest was -35.08%. And the median was -9.37%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Misonix's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul A Laviolette | director | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Sharon W Klugewicz | officer: Chief Operating Officer | 3661 HORSEBLOCK ROAD, MEDFORD NY 11763 |
Thomas M Patton | director | C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724 |
Joseph P Dwyer | officer: Chief Financial Officer | 3 CORDWOOD COURT, E. NORTHPORT NY 11731 |
Gwendolyn A Watanabe | director | C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030 |
Linwood A. Staub | officer: Sr. VP Wound | 8023 VANTAGE DRIVE SAN ANTONIO TX 78230 |
Stavros G. Vizirgianakis | director, officer: CEO | 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016 |
Robert S Ludecker | officer: SVP Sales - Surgical | 4 WILDBRIAR COURT MOUNT SINAI NY 11766 |
Allan Richard Staley | officer: President | C/O SOLSYS MEDICAL, LLC 600 THIMBLE SHOALS BLVD., SUITE 200 NEWPORT NEWS VA 23606 |
Michael Koby | director | C/O 1315 CAPITAL 2929 WALNUT STREET, SUITE 1240 PHILADELPHIA PA 19104 |
1315 Capital Management, Llc | 10 percent owner | 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104 |
Sv Life Sciences Fund Vi (gp), L.p. | 10 percent owner | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Svlsf Vi, Llc | 10 percent owner | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Sv Life Sciences Fund Vi Strategic Partners, L.p. | 10 percent owner | C/O SV LIFE SCIENCES ADVISERS, LLC, ONE BOSTON PLACE, SUITE 3900, BOSTON MA 02108 |
1315 Capital, L.p. | 10 percent owner | 3020 MARKET STREET, SUITE 104 PHILADELPHIA PA 19104 |
From GuruFocus
By GF Value GF Value • 03-31-2021
By Marketwired Marketwired • 01-21-2021
By Marketwired Marketwired • 04-20-2021
By Marketwired Marketwired • 09-23-2021
By Marketwired Marketwired • 11-12-2020
By Marketwired Marketwired • 06-15-2020
By Marketwired Marketwired • 09-21-2020
By Marketwired Marketwired • 09-15-2021
By Marketwired Marketwired • 10-06-2020
By Marketwired Marketwired • 05-22-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.